Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myramistin oromucosal spray dose-finding trial in acute pharyngitis
2018-002543-28Phase 2Terminated
- Sponsor
- Megapharm
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of miramistin in acute pharyngitis (4 arms), sponsored by Megapharm. Primary endpoint: SPID-2Pain. Started Oct 2019; status: terminated.
02
Drugs
miramistin
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on 2018-002543-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002543-28.